Compound Profile: Vilitra
Vilitra 60mg is a pharmaceutical-grade vardenafil hydrochloride preparation designed for advanced in-vitro research applications. As a potent PDE5 inhibitor compound, this formulation enables researchers to investigate phosphodiesterase enzyme mechanisms and vascular biology pathways in controlled laboratory environments. When researchers examine this compound, they can analyse its molecular interactions with cyclic GMP pathways and smooth muscle cell physiology. This preparation represents a standardised research tool from Stroid UK Shop for studies requiring pharmaceutical-grade vardenafil compounds.
Laboratory Applications
Research teams studying erectile dysfunction pathophysiology can utilise Vilitra 60mg to investigate PDE5 enzyme inhibition mechanisms in cell culture systems. The compound enables detailed analysis of nitric oxide signalling cascades and vascular endothelial function in laboratory models. Scientists examining cardiovascular research applications can study this preparation’s effects on smooth muscle relaxation pathways and blood flow regulation mechanisms. Researchers working with vardenafil research compounds benefit from this pharmaceutical-grade preparation’s consistent formulation. Studies of pulmonary hypertension mechanisms and vascular biology applications represent additional research directions where this compound proves valuable.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Vardenafil Hydrochloride |
| Dosage Strength | 60mg per tablet |
| Form | Pharmaceutical tablet |
| CAS Number | 224789-15-5 |
| Molecular Formula | C₂₃H₃₃ClN₆O₄S |
| Storage | Room temperature, dry environment |
| Solubility | Water soluble as hydrochloride salt |
Researchers investigating SARM compounds alongside PDE5 inhibitors can compare molecular pathways, while those studying peptide research applications may examine vascular effects in combination studies.
Research Compliance
This pharmaceutical preparation is intended exclusively for in-vitro laboratory research and analytical purposes. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must comply with institutional guidelines and regulatory requirements when handling this compound in laboratory environments.
